Assenagon Asset Management S.A. Raises Stock Holdings in Agilent Technologies, Inc. $A

Assenagon Asset Management S.A. lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 11.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 34,432 shares of the medical research company’s stock after acquiring an additional 3,605 shares during the period. Assenagon Asset Management S.A.’s holdings in Agilent Technologies were worth $4,063,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. lifted its position in Agilent Technologies by 0.7% during the 1st quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company’s stock worth $3,908,141,000 after acquiring an additional 240,965 shares during the period. Pictet Asset Management Holding SA lifted its stake in shares of Agilent Technologies by 2.5% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company’s stock worth $624,888,000 after acquiring an additional 128,131 shares during the period. Generation Investment Management LLP boosted its holdings in shares of Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company’s stock valued at $582,976,000 after acquiring an additional 824,243 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Agilent Technologies by 18.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company’s stock worth $448,748,000 after acquiring an additional 604,124 shares during the period. Finally, Impax Asset Management Group plc boosted its holdings in Agilent Technologies by 3.6% in the 1st quarter. Impax Asset Management Group plc now owns 2,931,794 shares of the medical research company’s stock valued at $342,961,000 after purchasing an additional 102,365 shares in the last quarter.

Agilent Technologies Stock Performance

Shares of A stock opened at $124.30 on Thursday. The company has a market capitalization of $35.24 billion, a price-to-earnings ratio of 29.18, a P/E/G ratio of 4.11 and a beta of 1.24. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock’s fifty day simple moving average is $120.85 and its 200-day simple moving average is $115.94. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm’s revenue was up 10.1% on a year-over-year basis. During the same period in the previous year, the company earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 23.24%.

Analysts Set New Price Targets

A has been the subject of a number of recent analyst reports. Evercore ISI reduced their target price on Agilent Technologies from $130.00 to $128.00 and set an “in-line” rating for the company in a report on Thursday, August 28th. JPMorgan Chase & Co. reduced their price objective on Agilent Technologies from $160.00 to $155.00 and set an “overweight” rating for the company in a report on Thursday, May 29th. Barclays restated an “equal weight” rating and issued a $125.00 target price on shares of Agilent Technologies in a report on Friday, August 29th. Wells Fargo & Company increased their price objective on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a report on Monday, September 15th. Finally, Robert W. Baird increased their price target on Agilent Technologies from $141.00 to $142.00 and gave the company an “outperform” rating in a report on Thursday, August 28th. Six analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $140.08.

Insider Buying and Selling

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $117.44, for a total transaction of $177,099.52. Following the completion of the transaction, the chief executive officer directly owned 37,448 shares in the company, valued at $4,397,893.12. This represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.